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Fever of unknown origin (FUO) is generally deﬁned as a fever greater than 38.3◦C on several occasions during a period longer
than 3 weeks for which the etiology behind cannot be diagnosed at the end of at least 1 week hospital stay. Conventional
diagnostic methods are still not adequate to reveal underlying reason in approximately 50% of patients with FUO. In patients
with certain diagnosis, three major categories are infections, malignancies, and noninfectious inﬂammatory diseases. Fluoro-18-
ﬂuoro-2-deoxy-D-glucose (FDG) is a structural analog of 2-deoxyglucose and accumulates in malignant tissues but also at sites of
infection and inﬂammation. For this reason, FDG PET or PET/CT has great advantage in understanding of underlying pathology
in assessment of FUO. However, till today, there are limited studies about the role of FDG PET or PET/CT in evaluation of FUO.
In this paper, the impact of FDG PET or PET/CT in the diagnostic work-up of FUO is described by data obtained from literature
review.
1. Classiﬁcationsof Fever of Unknown Origin
The classical deﬁnition of fever of unknown origin (FUO)
was made by Petersdorf and Beeson in 1961 as “a fever
that is measured to be above 38.3◦C on several occasions
during a period longer than 3 weeks for which the etiology
behind cannot be diagnosed at the end of at least 1 week
hospital stay [1]. In 1991, Durack and Street have made
two major changes on this deﬁnition. Firstly, they identiﬁed
and separated FUO types to nasocomial FUO, neutropenic
FUO, HIV-associated FUO, that require entirely diﬀerent
clinical approaches in diagnosis and treatment compared
with the classical deﬁnition. Secondly, the requirement of
at least 1-week hospital stay has been replaced with 3-
day hospital stay or 3 outpatient visits [2]. The prevalence
of FUO among adult-hospitalized patients is reported to
be 2.9% [3]. The spectrum of FUO etiology may include
more than 200 diseases [2]. The diseases causing FUO vary
depending on the geographical diﬀerences, development
level of countries; and the experience of clinicians [4].
According to the studies conducted to date, the diseases
taking part in FUO etiology and their rates are as follows:
infections (21–54%), noninfectious inﬂammatory causes
(13–24%), neoplasms (6–31%), and other causes (4–6.5%)
[4]. While in Middle East and Far East countries infections
are more frequently observed to be the underlying cause
of FUO, higher numbers of cases without diagnosis are
e n c o u n t e r e di nd e v e l o p e dc o u n t r i e s[ 2]. Tuberculosis (TB)
is the most common infectious disease that causes FUO in
developing countries; incidence of TB reported in Europe
and North America is about 5% [4]. The other commonly
encountered infectious diseases are endocarditis, typhoid
fever, malaria, brucellosis, cytomegalovirus infection, and
AIDS in western countries [4]. Giant cell arteritis, systemic
vasculitis, SLE, adult-onset Still’s disease, acute rheumatic
fever, and polymyalgia rheumatica can be mentioned among
noninfectious inﬂammatory causes [4, 5]. Diseases such as
subacute thyroiditis, sarcoidosis, ulcerative colitis, cirrhosis,
and drug fever can be mentioned among miscellaneous
causes of FUO that are not included in the other groups
[4, 6, 7].
The FUO causes among geriatric patients do not diﬀer
from those in adults [8, 9]. But deep vein thrombosis and
temporal arteritis are important considerations in elderly
patients [3]. In pediatric patients, infections take the ﬁrst








Figure 1: A 54-year-old woman with FUO underwent PET-CT for the diagnosis of underlying disease. Transaxial slices of CT (a1, b1),
fusion (a2, b2), and PET (a3, b3) and anterior MIP image (c) showed accumulation of FDG in the wall of thoracic aorta and the supra-aortal
branches. Gigantocellular arteritis was conﬁrmed subsequently by temporal arterial biopsy.
occur as localized infections [10, 11]. As the inﬂammatory
causes constitute 20.9% of all causes, rheumatic fever is the
most common one. Neoplasia incidence is 3%, and the rate
of undiagnosed cases is around 19.4% [10]. Recently, the
numberofundiagnosedcasesisobservedtorise.Thismaybe
due to the improvements in diagnostic methods which lead
to deﬁne the diseases that are hard to diagnose such as FUO
[6].
2. DiagnosticMethods in the Evaluationof
Feverof Unknown Origin
In patients presenting with FUO, basic diagnostic methods
are performed following detailed history and physical exam-
ination. As those methods can diﬀer between the clinics,
generally the following are employed: routine biochemical
blood tests, complete blood count, peripheral blood ﬁlm,
urinalysis, blood cultures, and chest X-ray [2]. In some
centers, abdominal USG and CT along with tuberculin skin
test and agglutination tests for Brucella are applied as well
[6].
The rate of failure to reach a deﬁnitive diagnosis in
patients with FUO varies between 7% and 53% [6]. In
FUO diagnosis, noninvasive methods are used in 69.2% of
cases, whereas invasive methods are preferred in 30.8% of
cases [2]. Temporal artery biopsy should be the ﬁrst-line
diagnostic method in absence of diagnostic clues among
elderly patients [6, 12]. In cases where imaging modalities
are not successful and ﬁne needle aspiration biopsies or
excisional biopsies fail, even exploratory laparotomy may
be performed. Although laparotomy is a less preferred
diagnostic method, its contribution to the diagnostic process
has been reported to be 2%–100% in the literature. It can
behelpfulparticularlyinTBandhematologicalmalignancies
[13]. In selected cases, response to empirical anti-TB therapy
may serve as a diagnostic method [8].
3.Nuclear Medicine Methods in Determination
of Fever of Unknown OriginEtiology
Nuclear medicine methods are generally categorized as





increased uptake of FDG in the pericardium. Viral pericarditis was diagnosed by ﬁne needle aspiration biopsy.
The most commonly applied methods are Ga-67 citrate
scan, labeled leukocyte scan (Tc-99m, In-111), labeled
immunoglobulin scan (Tc-99m or In-111), and FDG-PET
and PET/CT scan. Ga-67 scan shows acute, chronic, and
granulomatous infections and noninfectious inﬂammation
foci. It also demonstrates uptake in malignant tissues, and
therefore it could be the ﬁrst-line nuclear medicine method
for investigation of FUO [15, 16]. The assistance of Ga-
67 scan in patients with FUO has been reported to be
29% [14]. Its sensitivity and speciﬁcity are 67% and 78%,
respectively [17]. Low speciﬁcity of Ga-67 may be assumed
as an advantage considering the wide spectrum of diseases
causing FUO [15]. The disadvantages of Ga-67 scan are as
follows: low availability, high dose of radiation delivered to
the patient, long duration of imaging and reporting, and the
riskofsuperpositionofpathologicalfocionabdomenduring
intestinal elimination [15, 16].
ThesensitivityandspeciﬁcityofIn-111-labeledleukocyte
scan in detecting the acute and chronic infections are high
(60–85%, 78–94%, resp.), and uptake may also be observed
in some malignant conditions. Cold areas in scan may reﬂect
the metastatic foci or chronic infections [16, 18]. It has
been reported to be superior against Ga-67 scan particularly
in revealing the intra-abdominal events [15]. However, In-
111-labeled leukocyte scan takes too much time to perform.
Moreover, because the photon ﬂux of In-111 is low, it is
not suitable for SPECT [16]. Labeled leukocyte scans should
be used when there is evidence of a pyogenic focus behind
the FUO proﬁle. For instance, occult infection may be
mentioned in presence of a history of a surgical procedure
in the last 6 months, positive blood cultures, endocarditis,
and intravenous or peritoneal catheter, and therefore labeled
leukocyte scan may be preferred in these conditions [19].
Labeled immunoglobulin scan is a method that is
employed for diagnosing infections and inﬂammation foci.
The advantage of using radiolabeled monoclonal antibodies
(mAbs) against surface antigens on granulocytes is an easier
labeling procedure not requiring the handling of potentially
contaminated blood. However, the high molecular weight,
slow diﬀusion into the inﬂammation sites, a long plasma
half-life, and high uptake in the liver are disadvantages of
this method. There are few studies about the use of the
commercially available antigranulocyte antibodies. Murine
anti-NCA-95 IgG (BW 250/183) labeled with Tc99m recog-
nizes the nonspeciﬁc cross-reacting antigen 95 (NCA-95) on
human granulocytes. The reported diagnostic sensitivity and
speciﬁcity for infections were 40% and 92%; PPV and NPV
were 88% and 52%, respectively [20].
4. FDG-PETand PET/CTin Evaluationof
Fever ofUnknown Origin
Due to wide etiology spectrum of FUO, clinicians still expe-
rience diﬃculties in selecting and applying the diagnostic
procedures in those cases. Morphological changes may not
occur at early periods of infections and inﬂammation, both












Figure 3: A 58-year-old man with long standing FUO. Diﬀuse FDG accumulation in bone marrow with no extraosseous manifestations was
shown on the transaxial slices of CT (a1, b1), fusion (a2, b2), and PET (a3, b3) and anterior MIP image (c). Non-Hodgkin’s lymphoma was
diagnosed by bone marrow biopsy.
of that sensitivities of anatomical imaging, modalities such
as USG, CT, and MRI can be low. Moreover, since those
modalities only show certain parts of the body, they cannot
provide information on pathological events in systemic
disorders [21].
Fluoro-18 FDG is a structural analog of 2-deoxyglucose
and its half-life is 110min. There are three transport
mechanisms of glucose and F18-FDG into the cells; pas-
sive diﬀusion, active transport by Na+-dependent glucose
transporter, and the most important one for F18-FDG, with
facultative glucose transporters GLUT-1 through GLUT-13.
In tumor cells, an increased uptake of F18-FDG is seen; this
can be explained by overexpression of the GLUT isotypes—
mostly GLUT-1, GLUT-3, and GLUT-5- and overproduction
of glycolytic enzymes. The high uptake of F18-FDG in
inﬂammatory cells, granulation tissues, and granulomas is
duetothesimilarmechanismsseenintumorsespeciallywith
the overexpression of GLUT-1 and GLUT-3 [22]. FDG-PET
isavaluableimagingmethodforitssuccessindemonstrating
both neoplasms and infection-inﬂammation foci. Recently,
FDG-PET scan has been reported to be eﬀective in detection
and staging of malignancies and assessment of treatment
response.
S e v e r a ls t u d i e sh a v eb e e nr e p o r t e df o rt h eu s eo fF D G -
PET or PET/CT in classical FUO patients over the past 2
decades. These studies demonstrated that the contributions
totheﬁnaldiagnosisrangefrom16%to89%inpatientswith
FUO by FDG-PET or PET/CT (Table 1).
Similar to Ga-67 scan, the high sensitivity and relatively
low speciﬁcity of FDG-PET in determining the pathological
processes are considered as advantages due to wide spectrum
of diseases in FUO etiology [23]. Since the most common
3 etiologies of FUO are known to be infections, noninfec-
tious inﬂammatory events, and neoplasms, FDG-PET scan
appears to be a valuable modality in diagnosing the etiology
of FUO.
The study of Lorenzen et al. [24] is one of the ﬁrst
studies using FDG-PET in diagnosis of FUO, and they
found the contribution of FDG-PET to establishment of
diagnosis in a group of 16 patients as 69%. They noted
the absence of a pathological focus which could be the
underlying cause for fever among patients with negative
FDG-PET results and reported a high negative predictive
value for FDG-PET [24]. Bleeker-Rovers and colleagues [25]
retrospectively studied the contribution of FDG-PET to the
diagnostic process of patients in whom FUO or suspicious
infection and inﬂammation foci were investigated. While
diagnosis could be reached in 46% of 35 patients with
FUO, they found the contribution of FDG-PET to the











Figure 4: PET-CT of a 77-year-old man with FUO. Transaxial slices of CT (a1, b1), fusion (a2, b2), and PET (a3, b3), and anterior whole
body (c1), lower extremities (c2) MIP images revealed multiple foci in the walls of vessels. Nonspeciﬁc vasculitis was diagnosed by biopsy.
positive predictive value, and negative predictive value of
FDG-PET as 93%, 90%, 87%, and 95%, respectively [25].
Another study published 2 years later by the same group
evaluated the place of FDG-PET in FUO diagnosis by a
prospective and systematic approach. This study has been
performed before conventional radiological methods and
just after basic diagnostic methods. Diagnosis was reached
in 50% of 70 patients, and the contribution of FDG-PET
to the diagnosis was reported to be 33%. The sensitivity,
speciﬁcity, positive predictive value, and negative predictive
value of FDG-PET were found to be 88%, 77%, 70%, and
92%, respectively. In the same study, abdominal and thoracic
CTs were applied on a subgroup of 43 patients. While the
positive predictive value of abdominal and thoracic CT was
48% and negative predictive value was 86%, the positive
predictive value of FDG-PET was found to be 65% while6 International Journal of Molecular Imaging
Table 1: Review of literature on FDG PET or PET/CT in patients with fever of unknown origin.
Author
(Year)
Study design Patients number FDG-PET technique PET helpful (%) PPV (%) NPV (%)
Meller et al.
(2000)
Prospective 18 Coincidence camera 55 92 75
Blockmans et al.
(2001)
Prospective 58 Full-ring PET 41 — —
Lorenzen et al.
(2001)
Retrospective 16 Full-ring PET 69 92 100
Bleeker-Rovers et al.
(2004)
Retrospective 35 Full-ring PET 37 87 95
Kjaer et al.
(2004)
Prospective 19 Full-ring PET 16 30 67
Buysschaert et al.
(2004)
Prospective 74 Full-ring PET 26 — —
Bleeker-Rowers et al.
(2007)
Prospective 70 Full-ring PET 33 70 92
Keidar et al.
(2008)
Prospective 48 PET/CT scan 46 81 100
Balink et al.
(2009)
Retrospective 68 PET/CT scan 55 93 78
Federici et al.
(2010)
Retrospective 10 PET/CT scan 50 — —
Jasper et al.
(2010)
Retrospective 44 Full-ring PET or PET/CT scan 43 — —
Ferda et al.
(2010)
Retrospective 48 PET/CT scan (contrast-enhanced CT) 89 97 75
Keia et al.
(2010)
Retrospective 12 PET/CT scan 42 71 100
Ergul et al.∗ Retrospective 28 PET/CT scan 50 63 100
Total: 548 Mean values: 47 78 88
∗Unpublished data, PPV: positive predictive value, NPV: negative predictive value.
negative predictive value was 90% [26]. Buysschaert et al.
conducted a study on 74 patients with FUO and succeeded
to diagnose 53 of them while ﬁnding the contribution of
FDG-PET as 26% [27]. Jaruskova and Belohlavek reported
contribution of FDG-PET or PET/CT to the diagnosis as
36% among 118 (94 had FUO) patients with prolonged fever
[21]. Federici et al. performed a study on 14 patients (10
with FUO and 4 with prolonged inﬂammatory syndrome)
and reported the contribution of FDG-PET to the diagnosis
as 50% [28]. Keidar et al. [29] prospectively studied the role
of FDG PET/CT in 48 patients with FUO. They reported
the performance of PET/CT in FUO evaluation showing
sensitivity of 100%, speciﬁcity of 81%, PPV of 81%, NPV of
100%, and accuracy of 90%. Balink et al. [30] have recently
found that the contribution of FDG PET/CT to diagnosis
in 68 patients with FUO elevated erythrocyte sedimentation
rate and C-reactive protein as 56%. They reported a high
negative predictive value of 100% for focal etiologies of
FUO excluding the systemic diseases [30]. In one of the
most recent studies conducted by Keia et al. [31], FDG-
PET/CT was found helpful for diagnosis in 41.6% of 12
patients with FUO. Jasper et al. [32]p e r f o r m e das t u d y
about the diagnostic value of FDG-PET and PET/CT in
diagnosis of FUO in pediatric patients. In this retrospective
study, 47 PET and 30 PET/CT scans were performed in 69
children having unexplained inﬂammatory signs including
fever, increased leucocyte count, CRP, and ESR. Of all the
PET and PET/CT scans, 45% were helpful to diagnosis. The
ﬁnal diagnosis was established in 54% of the patients, and
among these patients, scans were contributory in 73%. The
combinationofPETwithlow-doseCTwasfoundsuperiorto
PET without CT in this study [32]. In our unpublished study
results, the contribution of FDG-PET/CT on diagnostic
process was found to be 50%, and the sensitivity, speciﬁcity,
positive predictive value, and negative predictive value of
FDG-PET/CT were found to be 92%, 45%, 63%, and 100%,
respectively. In our study, the underlying etiologies of FUO
were neoplasms in 41.6%, infection in 16.7%, noninfectious
inﬂammatory events in 16.7%, and miscellaneous causes in
25% of patients. This result is probably due to elimination
of TB and Brucellosis, which are common causes of FUO
in our country, by applying speciﬁc diagnostic tests at the
beginning. Similar to the previous studies in the literature,
lymphomas have been found to be the most common
reason disease among our patients with neoplasms [4,
33].International Journal of Molecular Imaging 7
There are also studies which compare the FDG-PET
and other nuclear medicine methods in FUO diagnosis
[17, 34, 35]. Meller et al. [17]p e r f o r m e das t u d yo n2 0
patients with FUO by using a double-head coincidence
camera and demonstrated the contribution of FDG-PET to
diagnosis as 55%. They applied Ga-67 scintigraphy on a
subgroup of 18 patients. The sensitivity, speciﬁcity, positive,
andnegativepredictivevaluesoftransaxialFDGtomography
were found to be 81%, 86%, 92%, and 75%, respectively.
The sensitivity, speciﬁcity, positive, and negative predictive
values of Ga-67 were reported to be 67%, 78%, 75%, and
70%, respectively [17]. Blockmans et al. [34] found the
contributionofFDG-PETtothediagnosisof58patientswith
FUO as 41%. They performed both FDG-PET and Ga-67
citrate scan on a subgroup of 40 patients and determined
the contribution of FDG-PET to the diagnosis as 35%,
while the contribution of Ga-67 scan was 25%. Moreover,
entire pathological foci detected on Ga-67 citrate scan were
noted to be found on the FDG-PET scan as well [34].
Although Ga-67 scan is preferred as the ﬁrst-line scanning
method due to its success in detection of neoplasms and
inﬂammatoryevents,itsdisadvantagessuchashighradiation
dose, long duration of procedure and evaluation, and low
spatial resolution render FDG-PET a more valuable method
[15–17].
T h es e n s i t i v i t ya n ds p e c i ﬁ c i t yo fl a b e l e dl e u k o c y t es c a n s
in demonstrating infectious and inﬂammatory events are
high. However, because FDG-PET can also display the
neoplasms, it seems to be superior in FUO diagnosis. Kjaer
et al. [35] compared In-111-labeled leukocyte scan with
FDG-PET in 19 patients with FUO and acquired a diﬀerent
result. While they found the sensitivity and speciﬁcity of
FDG-PET as 50% and 46%, respectively, the sensitivity and
speciﬁcity of the In-111 granulocyte scan was 71% and 92%,
respectively. The positive and negative predictive values of
FDG-PET were 30% and 67%, respectively, whereas both
of those values were 85% in In-111 scan. Twelve (63%)
patients out of 19 were diagnosed; and while infection was
determinedin7patients,autoimmunediseasesweredetected
in 3, uric acid synovitis in 1, and Hodgkin lymphoma in
again1patient.TheFDG-PETwasreportedtobeinadequate
for detection of infection foci and its speciﬁcity and positive
predictive value were found to be low due to false positive
results. They reported In-111 as a superior modality for
determining infections compared with the FDG-PET [35].
However, although neoplasms constituted only 5% of the
etiology spectrum, the rate of neoplasms among etiology of
FUO cases has been shown to have the potential to reach up
to 30% in the literature [2, 4]. Therefore, since the results
obtained were from a speciﬁc FUO group, they may not be
reﬂecting the characteristics of overall population.
FDG-PET has been reported to be superior to other
imaging modalities in FUO diagnosis and particularly for
detection of vasculitis [17, 28, 34]. Giant cell arteritis
(temporal arteritis) and Takayasu arteritis constitute 17%
of all FUO causes. FDG uptake has been shown in cases
of giant cell arteritis, polymyalgia rheumatica, Takayasu
arteritis,peritonitisassociatedwithWegenergranulomatosis,
and infectious vasculitis [36]. The sensitivity and speciﬁcity
of FDG-PET in detection of vasculitis have been reported
to be 77–100% and 89–100%, respectively [5]. Mostly, CT
and MRI are employed for diagnosis of Takayasu arteritis;
however, especially for lesions of early stage, FDG-PET
has been found to be more eﬀective [37]. In cases where
giant cell arteritis is limited only with temporal arteries,
the sensitivity of FDG-PET may be low as a result of small
vascular diameter and high background activity in brain
[36]. Ferda et al. [38] performed a study with 48 FUO
patients using complex FDG PET/CT protocol combined
PET and integrated whole diagnostic contrast-enhanced CT
with submillimeter spatial resolution. CT data contained
diagnostic images reconstructed with soft tissue and high-
resolution algorithm. They found the sensitivity of this
protocol as 97% and speciﬁcity as 75%. In this study, it was
emphasized that the whole diagnostic CT investigations play
an important role in diagnosis of FUO with assessment of
solid abdominal organs, mainly liver parenchyma, intestinal
wall, and also the structure of the pulmonary parenchyma
where it may be impossible to evaluate the interstitial tissue
inﬁltration with PET because the size of the changes is below
its spatial resolution threshold [38].
Examples of diagnostic role of FDG PET/CT in inﬂam-
mation, infection and neoplasia are presented in Figures 1–4.
5. Conclusion andFutureProspects
Although FDG PET/CT is a state-of-the-art procedure for
the assessment of multiple malignancies, it is still not a
routine procedure in the workup of FUO due to high cost
and limited availability. However, the experience with FDG-
PET/CT should eliminate application of many unnecessary
invasive and noninvasive diagnostic techniques for detection
of main disease underlying FUO etiology. Currently, data in
the literature indicate that FDG-PET has an important role
as a second-line procedure in the management of nearly 50%
of patients with FUO. Even though the results of previous
FDG-PET studies are promising, still prospective studies
using PET/CT on larger populations of FUO are limited. It
is well known that hybrid PET/CT improves the diagnostic
impact of FDG PET in malignant diseases. For this reason,
accurate diagnosis of primary diseases in the context of FUO
is expected to increase.
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